‌

US Patent 8263658 Anthranilic acid derivatives

Patent 8263658 was granted and assigned to Chelsea Therapeutics International on September, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Chelsea Therapeutics International

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82636580

Patent Inventor Names

Ingela Fritzson0

Ulf Vellmar0

Leif Svenson0

Helén Tuvesson Andersson0

Ingrid Hallin0

Date of Patent

September 11, 2012

Patent Application Number

125353580

Date Filed

August 4, 2009

Patent Primary Examiner

‌

Paul Zarek

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8263658 Anthranilic acid derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API